Medical form for a patient with malignant melanoma of the skin, made in accordance to the most recent guidelines for diagnosing, treating and monitoring the disease
DOI:
https://doi.org/10.66344/jpad.v28i2.1127Keywords:
Malignat melanoma, treating, monitoring, medical formAbstract
The malignant melanoma of the skin is a vary rare malignant tumor, originating from the epidermal melanocytes. In Bulgaria the average morbidity is 6.5/100000. The tumor affects the younger age and often metastasizes in the early stages of the disease. MM of the skin is also the tumor with the highest rate of increase of morbidity. All of this imposes the usage of an unified tactic for diagnosing, treating and monitoring patients with that disease, aiming to achieve maximized beneficial effect for them, and said tactic to be marked in a fitting, simplified, but understandable, medical form.
Â
References
1. Balabanova M, Saleva M; Malignant Melanoma. MedInfo. 2016;4:24-9.
2. Wolff K, Johnson R, Fitzpatrick T. Melanoma precursors and primary cutaneous melanoma. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 6th edn. Ebook. New York: McGraw-Hill; 2009.
3. NCCN Clinical Practice Guidelines in Oncology: Melanoma. 2017. Available from: http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf
4. Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:126-32.
5. Marsden JR, Newton-Bishop JA, Burrows L, Raja EA, Iversen L, Brewster DH et al. Revised UK guidelines of care for the management of cutaneous melanoma. Br J Dermatol. 2010;163:238-56.
6. Dummer R, Guggenheim M, Arnold AW, Braun R, von Moos R; Project Group Melanoma of the Swiss Group for Clinical Cancer Research. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2011;5;141:w13320
7. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T et al. German Malignant Melanoma S3-Guideline “diagnosis, therapy and follow-up of melanoma.” J Dtsch Dermatol Ges. 2013;11 Suppl 6:1-116, 1-126
8. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. 2008. Available from: www.nhmrc.gov.au/guidelines/publications/cp111.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Strahil Strashilov, Veselin Kirov, Angel Yordanov, Vasil Nanev, Miroslava Mihailova, Ilko Iliev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
